Item | Group A(n = 95) | Group B(n = 129) | P |
---|---|---|---|
Gender (M/F) | 45/50 | 58/71 | / |
Age (year) | 1.33 ± 0.62 | 1.31 ± 0.76 | > 0.05 |
Weight (kg) | 9.73 ± 2.42 | 9.67 ± 2.53 | > 0.05 |
Cardiothoracic ratio | 0.58 ± 0.28 | 0.57 ± 0.28 | > 0.05 |
Size of VSD (mm) | 4.90 ± 3.05 | 4.40 ± 3.08 | > 0.05 |
Types of VSD (TTE) | |||
Subpulmonic VSD(n, %) | 14(14.73%) | 18(13.95%) | > 0.05 |
Permembranous VSD(n, %) | 68(71.6%) | 90(69.77%) | > 0.05 |
Muscular VSD(n, %) | 13(13.68%) | 21(16.28%) | > 0.05 |
Pulmonary arterial pressure grading (TTE) | |||
Nomal(n, %) | 78(82.11%) | 102(79.07%) | > 0.05 |
Mild(n, %) | 10(10.53%) | 15(11.63%) | > 0.05 |
Moderate(n, %) | 5(5.26%) | 8(6.20%) | > 0.05 |
Severe(n, %) | 2(2.10%) | 4(3.10%) | > 0.05 |
Pulmonary infection(n, %) | 10(10.53%) | 15(11.63%) | > 0.05 |
Cardiac insufficiency(n, %) | 9(9.47%) | 13(10.07%) | > 0.05 |
Period of follow-up (month) | 12 | 12 | / |